Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia
CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
ArchitectureAU2d
Reading room: The evolution and impact of three Australian architecture practices
In celebration of the milestone, architect and director of the practice Hamilton Wilson has authored a monograph to reflect ...
Artnet2d
These Newly Restored Films Reveal a Rare Glimpse Into Warhol’s Silver Factory
Three films by Gerard Malanga, Andy Warhol's closest collaborator, are newly restored, offering a rare glimpse into the ...
MyChesCo on MSN2d
FDA Proposes Removal of Oral Phenylephrine from OTC Nasal Decongestants
The U.S. Food and Drug Administration (FDA) has taken a pivotal step in consumer protection by proposing the removal of oral phenylephrine as an active ingredient in over-the-counter ...
Motor Authority3d
Infiniti Autograph Lounge SEMA concept is tailgating for the rich
Infiniti parent Nissan brought its own tailgating rig to SEMA in the form of Project Trailgater, a 2025 Frontier pickup truck ...
Bates College5d
Three Bates professors earn Phillips Fellowships for research and travel in 2025–26
They will research China's agricultural history; the intersection of immigration, incarceration, and public health in 19th-century New York City; and Caribbean immigrants' use of cricket and reggae to ...
FDA Proposes Banning Oral Phenylephrine As OTC Monograph Nasal Decongestant
The U.S. Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter (OTC) monograph ...
FDA Proposes Oral Phenylephrine Shouldn't Be Used in Certain OTC Nasal-Congestion Drugs
Oral phenylephrine, a common nasal-congestion ingredient in over-the-counter drugs, shouldn't be used in monograph drug products, the Food and Drug Administration is proposing. The agency said a ...